Related Experiment Video
Updated: Jul 22, 2025

04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
836
First Experience of Single-Port Robotic Areolar Approach Thyroidectomy
Yun Suk Choi1,2, Ji Hyun Choi2, Mi Sook Jeon2
1Department of Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Clinical and Experimental Otorhinolaryngology
|July 21, 2023
Summary
This study introduces single-port robotic areolar thyroidectomy (SPRA), a new minimally invasive technique. SPRA shows promising initial results with no vocal cord palsy or hypoparathyroidism, offering a scarless option for thyroid surgery.
Area of Science:
- Minimally Invasive Surgery
- Robotic Surgery
- Endocrine Surgery
Background:
- Minimally invasive thyroidectomy techniques are widely used globally.
- The da Vinci SP system offers potential for advanced robotic surgical approaches.
Purpose of the Study:
- To describe a novel minimally invasive thyroidectomy technique using the da Vinci SP system.
- To present the preliminary clinical outcomes of single-port robotic areolar thyroidectomy (SPRA).
Main Methods:
- A 3-cm semi-circular incision on the right areola and an 8-mm incision on the left areola were utilized.
- Hydro-dissection and an advanced bipolar device created a subcutaneous flap for instrument insertion.
- The da Vinci SP system was inserted via the right areolar incision for the procedures.
Main Results:
- Twenty-one SPRA procedures were performed between December 2022 and March 2023.
- Procedures included lobectomy (17), isthmectomy (2), and total thyroidectomy (2).
- No instances of vocal cord palsy or hypoparathyroidism were observed, with a mean flap time of 14.9 minutes and console time of 62.4 minutes.
Conclusions:
- The novel single-port robotic areolar thyroidectomy (SPRA) was successfully developed and performed.
- SPRA is a less invasive technique with no visible scars.
- Further comparative studies are needed to fully assess SPRA's efficacy.

